Taj Pharmaceuticals – Leading Manufacturer & Supplier of Rasagiline Tablets 1mg in India
Taj Pharmaceuticals Ltd., headquartered in Vapi, Gujarat, proudly stands as a pioneering manufacturer, exporter, and supplier of Rasagiline Tablets 1mg, serving both the domestic Indian market and international markets across Africa, the Middle East, and Latin America (LTAM). With a rock-solid reputation for pharmaceutical excellence, purity, and consistent quality, Taj Pharmaceuticals has earned global trust in the production and distribution of Rasagiline – a critical medication used for the management of Parkinson’s disease.
What Is Rasagiline and Why It Matters
Rasagiline belongs to a class of medications known as monoamine oxidase-B (MAO-B) inhibitors. It plays a vital role in managing symptoms of Parkinson’s disease by increasing dopamine levels in the brain, a neurotransmitter necessary for regulating movement.
As Parkinson’s disease advances, dopaminergic neurons decrease, resulting in tremors, stiffness, and impaired movement. Rasagiline Tablets 1mg work effectively by blocking MAO-B enzymes, which break down dopamine. This prolongs dopamine activity, leading to improved motor control in patients.
Taj Pharmaceuticals – The Benchmark for Quality Rasagiline Manufacturing
Taj Pharmaceuticals has been recognized as the top manufacturer and supplier of Rasagiline Tablets 1mg in India, offering an unmatched combination of affordability, efficacy, and regulatory compliance.
Our state-of-the-art manufacturing unit in Vapi, Gujarat complies with WHO-GMP, ISO, and GLP certifications. Every tablet is crafted with precision and undergoes rigorous quality checks to ensure maximum therapeutic efficacy and safety.
Rasagiline Tablets 1mg – Product Specifications
- Brand Name: Rasagiline Tablets 1mg
- Composition: Rasagiline Mesylate equivalent to Rasagiline 1mg
- Form: Oral Tablets
- Pack Size: Blister packs of 10 tablets or as required
- Usage: Management of Parkinson’s Disease
- Storage: Store in a cool, dry place away from sunlight
Taj Pharmaceuticals ensures global-standard packaging to maintain the stability and shelf-life of the product throughout its transportation and usage lifecycle.
Therapeutic Uses of Rasagiline Tablets 1mg
Rasagiline is prescribed in both monotherapy and adjunct therapy alongside other Parkinson’s medications such as Levodopa. It helps in:
- Reducing tremors and rigidity
- Improving bradykinesia (slowness of movement)
- Enhancing daily motor function
- Decreasing “off” time in advanced Parkinson’s cases
Side Effects and Precautions
While Rasagiline Tablets 1mg are generally well-tolerated, patients may experience:
- Headache
- Dizziness
- Mood changes
- Nausea
- Sleepiness
Caution is advised when operating heavy machinery or driving due to possible drowsiness or dizziness. Sudden posture changes may cause lightheadedness.
Patients should inform their healthcare provider if they are taking:
- Antidepressants
- Other MAO inhibitors
- Pain relievers (e.g., tramadol, meperidine)
Combining such drugs may lead to serotonin syndrome, a serious and potentially fatal condition.
Why Choose Taj Pharmaceuticals for Rasagiline Tablets?
1. PAN India & Global Supply Chain
We have a robust distribution network that spans the entire Indian subcontinent and reaches across to:
- Africa
- Middle East
- Latin America (LTAM)
- Southeast Asia
Our export operations are streamlined for timely delivery, with full custom documentation support and regulatory compliance in the destination country.
2. PCD Pharma Franchise Opportunities
Taj Pharmaceuticals extends exclusive PCD Pharma Franchise opportunities for Rasagiline Tablets 1mg across India. Distributors, wholesalers, and entrepreneurs can leverage:
- Monopoly rights
- Marketing support
- Promotional materials
- Attractive profit margins
3. Competitive Pricing Without Compromising Quality
With a commitment to affordability, we offer Rasagiline Tablets 1mg at the best price in Mumbai, Maharashtra, and throughout India. Our efficient production processes and volume-based scaling help keep costs down without affecting quality.
4. Regulatory Accreditations
- WHO-GMP Certified
- ISO 9001:2015
- DCGI Approved formulations
- FSSAI Registered
We ensure full compliance with pharmacopeial standards (IP/USP/BP/EP) and international export regulations.
Rasagiline Tablets 1mg – PAN India Coverage
We proudly serve major cities and states across India, including:
- Mumbai, Maharashtra
- Delhi NCR
- Chennai, Tamil Nadu
- Hyderabad, Telangana
- Ahmedabad, Gujarat
- Kolkata, West Bengal
- Lucknow, Uttar Pradesh
- Bhopal, Madhya Pradesh
- Bengaluru, Karnataka
Taj Pharmaceuticals ensures seamless availability of Rasagiline Tablets 1mg through our extensive logistics network, fulfilling both bulk institutional requirements and individual pharmacy consignments.
Trusted Rasagiline Manufacturer & Exporter – Beyond Borders
As a leading exporter, Taj Pharmaceuticals has established strong alliances with government agencies, NGOs, hospitals, and pharmacies in:
- Kenya
- Uganda
- Nigeria
- UAE
- Saudi Arabia
- Peru
- Colombia
- Vietnam
We provide regulatory documentation, COAs, MSDS, and stability data for seamless registration in importing countries.
Get in Touch – Source Rasagiline Tablets Directly from the Manufacturer
Whether you are a hospital buyer, distributor, or pharma entrepreneur, sourcing Rasagiline Tablets 1mg directly from Taj Pharmaceuticals guarantees:
- Authentic, high-quality medication
- Cost-effective pricing
- Reliable delivery timelines
- Responsive client support
Head Office: Taj Pharmaceuticals Ltd., Vapi, Gujarat, India
Manufacturing Units: Multiple WHO-GMP Certified Units in Gujarat and Maharashtra
Email: info@tajpharma.com
Phone: +91-22-2637-4592 / +91-98201-55050
Rasagiline Tablets 1mg from India’s Trusted Pharma Partner
Taj Pharmaceuticals is India’s leading Rasagiline Tablets 1mg manufacturer, known for its quality commitment, global compliance, and pharma excellence. With decades of experience, cutting-edge infrastructure, and client-centric ethics, we stand at the forefront of the Parkinson’s disease treatment segment globally.
